Lai Wang Bei Gene, Ltd. (BGNE) insider trading activity

BGNE Quotes by TradingView

Lai Wang is Global Head of R&D of BeiGene, Ltd.. Currently has a direct ownership of 990,171 shares of BGNE, which is worth approximately $224 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 69,251 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 990K
Infinity% 3M change
Infinity% 12M change
Total Value Held $224 Million

Lai Wang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2025
BUY
Grant, award, or other acquisition
-
69,251 Added 6.54%
990,171 Ordinary Shares
Jun 24 2024
SELL
Open market or private sale
$170,718 $160.45 p/Share
1,064 Reduced 100.0%
0 American Depositary Sh...
Jun 18 2024
SELL
Open market or private sale
$129,303 $153.75 p/Share
841 Reduced 100.0%
0 American Depositary Sh...
Jun 17 2024
SELL
Open market or private sale
$238,799 $159.2 p/Share
1,500 Reduced 64.08%
841 American Depositary Sh...
Jun 05 2024
BUY
Grant, award, or other acquisition
-
168,935 Added 8.72%
1,768,962 Ordinary Shares
Jun 26 2023
SELL
Open market or private sale
$202,243 $182.53 p/Share
1,108 Reduced 100.0%
0 American Depositary Sh...
Jun 20 2023
SELL
Open market or private sale
$254,956 $192.42 p/Share
1,325 Reduced 100.0%
0 American Depositary Sh...
Jun 15 2023
BUY
Grant, award, or other acquisition
-
133,627 Added 7.64%
1,614,431 Ordinary Shares
Jun 07 2023
SELL
Open market or private sale
$103,797 $224.67 p/Share
462 Reduced 100.0%
0 American Depositary Sh...
Jun 27 2022
SELL
Open market or private sale
$81,213 $177.32 p/Share
458 Reduced 100.0%
0 American Depositary Sh...
Jun 22 2022
BUY
Grant, award, or other acquisition
-
125,255 Added 7.66%
1,509,989 Ordinary Shares
Jun 21 2022
SELL
Open market or private sale
$107,734 $149.01 p/Share
723 Reduced 100.0%
0 American Depositary Sh...
Jun 17 2022
SELL
Open market or private sale
$62,033 $139.4 p/Share
445 Reduced 38.1%
723 American Depositary Sh...
Jun 06 2022
SELL
Open market or private sale
$93,720 $142.0 p/Share
660 Reduced 100.0%
0 American Depositary Sh...
May 17 2022
BUY
Exercise of conversion of derivative security
$3,566,107 $2.89 p/Share
1,233,947 Added 46.7%
1,408,498 Ordinary Shares
Sep 28 2021
SELL
Bona fide gift
-
58,188 Reduced 25.0%
174,551 Ordinary Shares
Jun 28 2021
SELL
Open market or private sale
$164,928 $362.48 p/Share
455 Reduced 100.0%
0 American Depositary Sh...
Jun 18 2021
SELL
Open market or private sale
$265,582 $331.15 p/Share
802 Reduced 100.0%
0 American Depositary Sh...
Jun 16 2021
BUY
Grant, award, or other acquisition
-
53,625 Added 18.35%
238,654 Ordinary Shares
Jun 07 2021
SELL
Open market or private sale
$232,395 $354.26 p/Share
656 Reduced 100.0%
0 American Depositary Sh...
LW

Lai Wang

Global Head of R&D
Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BGNE